Septem 20gust 20simple
Sword 20red 20orange 20trans 20 5bsmall 5d

Sword Diagnostics

Accelerating Drug Development through dramatically enhanced sensitivity and reproducibility, without the need for special instrumentation, or complex processes.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Chicago, IL, US
  • Currency USD
  • Founded April 2005
  • Employees 13
  • Incorporation Type C-corp
  • Website sworddx.com

Company Summary

Sword gives pharmaceutical companies the very thing they value most, a faster time to market. Sword enhances their 50 year old testing technology with higher sensitivity and precision, allowing scientists to make better decisions faster, accelerating drug development. Sword's customers include Bristol-Myers Squibb, Eli Lilly, and Novartis, and the company is currently working with seven of the top 20 pharmaceutical companies in the world.

Team

Advisors

  • Default avatar
    Mary Beth Kerrigan - Morse, Barnes-Brown, & Pendleton, PC, Waltham, MA
    Lawyer
    Unconfirmed
    Default avatar
    Ted Hollander, CPA - Complus Inc., Chicago, IL
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    NJTC Ventures
    Unconfirmed
    Default avatar
    Keiretsu Forum
    Unconfirmed
    Default avatar
    Calvert Group
    Unconfirmed
  • Default avatar
    Heartland Angels
    Unconfirmed
    Default avatar
    Elevate Ventures
    Unconfirmed
    Default avatar
    Ellipsis Ventures
    Unconfirmed